Long-Term Assets: The sum of all assets classified as non-current.
Conduit Pharmaceuticals Inc. (CDT) had Long-Term Assets of $1.37M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-5.15M |
|
-- |
|
-- |
|
$4.01M |
|
$-4.01M |
|
$-1.14M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-4.01M |
|
$-3.45M |
|
3.89M |
|
3.89M |
|
$-1.32 |
|
$-1.32 |
|
Balance Sheet Financials | |
$5.95M |
|
$0.04M |
|
Long-Term Assets |
$1.37M |
$7.32M |
|
$4.55M |
|
-- |
|
$0.09M |
|
$4.63M |
|
$2.69M |
|
$2.69M |
|
$2.69M |
|
9.51M |
|
Cash Flow Statement Financials | |
$-4.33M |
|
$-0.00M |
|
$5.93M |
|
$0.55M |
|
$2.13M |
|
$1.58M |
|
$0.23M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
0.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-191.51% |
|
-191.51% |
|
-70.29% |
|
-191.51% |
|
$0.28 |
|
$-1.12 |
|
$-1.11 |